Syneron Medical Ltd (ELOS)

11.00
0.00 (0.00)
Prev Close 11.00
Open 10.95
Day Low/High 10.95 / 11.00
52 Wk Low/High 6.10 / 10.78
Volume 122.61K
Avg Volume 554.90K
Exchange
Shares Outstanding 35.23M
Market Cap 387.56M
Div & Yield N.A. (N.A)

Latest News

Syneron Candela Announces New Technology And Indications At The 2017 American Academy Of Dermatology (AAD) Annual Meeting

Updates Include CE Mark Approval for GentleTouch® Hair Removal System, FDA Clearance on PicoWay Resolve® for Acne Scars, Availability of UltraShape Power® and FDA Clearance of Profound® to Improve the Appearance of Cellulite

Relative Strength Alert For Syneron Medical

Relative Strength Alert For Syneron Medical

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Syneron Medical Enters Oversold Territory (ELOS)

Syneron Medical Enters Oversold Territory (ELOS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Syneron Medical Enters Oversold Territory (ELOS)

Syneron Medical Enters Oversold Territory (ELOS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Syneron Medical Becomes Oversold (ELOS)

Syneron Medical Becomes Oversold (ELOS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Relative Strength Alert For Syneron Medical

Relative Strength Alert For Syneron Medical

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Syneron Medical (ELOS)

Oversold Conditions For Syneron Medical (ELOS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Syneron Medical Enters Oversold Territory (ELOS)

Syneron Medical Enters Oversold Territory (ELOS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting ELOS Call Options For April 17th

Interesting ELOS Call Options For April 17th

Investors in Syneron Medical Ltd saw new options begin trading this week, for the April 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ELOS options chain for the new April 17th contracts and identified the following call contract of particular interest.

4 Stocks Spiking on Big Volume: Ryanair, Trex and More

4 Stocks Spiking on Big Volume: Ryanair, Trex and More

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Syneron Medical (ELOS) Stock Spikes Today on Strong Fourth Quarter Guidance

Syneron Medical (ELOS) Stock Spikes Today on Strong Fourth Quarter Guidance

Syneron Medical (ELOS) shares are climbing double digits after the company issued fourth quarter revenue guidance ahead of analysts' expectations.

4 Stocks Under $10 Making Big Moves Higher

4 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Syneron Medical is Now Oversold (ELOS)

Syneron Medical is Now Oversold (ELOS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Syneron Medical is Now Oversold (ELOS)

Syneron Medical is Now Oversold (ELOS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Under $10 Making Big Moves

5 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Syneron Medical Ltd. Stock Upgraded (ELOS)

Syneron Medical Ltd. Stock Upgraded (ELOS)

Syneron Medical (Nasdaq:ELOS) has been upgraded by TheStreet Ratings from a sell to hold.

Syneron Medical Ltd. Stock Downgraded (ELOS)

Syneron Medical Ltd. Stock Downgraded (ELOS)

Syneron Medical (Nasdaq:ELOS) has been downgraded by TheStreet Ratings from from a hold to sell.

Syneron Medical's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Syneron Medical's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Syneron Medical's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Nose Jobs Take a Nosedive

Names tied to the cosmetic medical market will be vulnerable until consumer sentiment and disposable income rebound.

Syneron Medical's CEO Hosts Investor Meeting Conference (Transcript)

Syneron Medical's CEO Hosts Investor Meeting Conference (Transcript)

Syneron Medical's CEO Hosts Investor Meeting Conference (Transcript)

Syneron Medical's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Syneron Medical's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Syneron Medical's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Syneron Medical's Management Presents At The Lazard Capital Markets 8th Annual Healthcare Conference (Transcript)

Syneron Medical's Management Presents At The Lazard Capital Markets 8th Annual Healthcare Conference (Transcript)

Syneron Medical's Management Presents at the Lazard Capital Markets 8th Annual Healthcare Conference (Transcript)

Syneron Medical's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Syneron Medical's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Syneron Medical's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Syneron's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Syneron's CEO Discusses Q3 2011 Results - Earnings Call Transcript